Compare Amylx Pharmaceuticals Inc (AMLX) vs SpaceX (SPCX) Price & Performance

Amylx Pharmaceuticals IncTrade

SpaceXTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs SpaceX — how do they compare? Amylx Pharmaceuticals Inc trades at $23.66 (market cap $2.64B), while SpaceX trades at $137.86 (market cap $1.76T). The key difference: SpaceX is far larger — about 666.7× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.

	AMLX	SPCX
Market Cap	$2.64B	$1.76T
Sector	Health	Technology
52-Week High	$24.19	$202.09
52-Week Low	$7.82	$108.27
Enterprise Value	$2.39B	$1.70T

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMLX

View details →

SPCX

SpaceX shares rebound near IPO price amid ambitious $1T revenue goal by 2030, but timeline seen as aggressive.24/7 Wall Street · 4 hours agoBullish SpaceX's AI revenue soars 247% YoY, set to dominate by Q3 with $300B potential by 2027Seeking Alpha · 5 hours agoBullish Investor Ron Baron predicts SpaceX could reach a $40 trillion valuation in 15 years, echoing his successful Tesla bet.24/7 Wall Street · 5 hours agoBullish View details →

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.